Publication

Anti-sars-cov-2 antibodies and use thereof in the treatment of sars-cov-2 infection

Didier Trono, Priscilla Turelli
2022
Patent

Abstract

The invention provides anti-SARS-CoV-2 antibodies and use thereof in prophylaxis, treatment and/or attenuation of a SARS-CoV-2 virus infection.

Official source

https://infoscience.epfl.ch/record/296470?ln=en

About this result

This page is automatically generated and may contain information that is not correct, complete, up-to-date, or relevant to your search query. The same applies to every other page on this website. Please make sure to verify the information with EPFL's official sources.

Graph Chatbot

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.

Anti-sars-cov-2 antibodies and use thereof in the treatment of sars-cov-2 infection

Graph Chatbot

Chat with Graph Search

Anti-sars-cov-2 antibodies and use thereof in the treatment of sars-cov-2 infection

Challenges of COVID-19 Case Forecasting in the US, 2020-2021

Cryo-EM structures and binding of mouse and human ACE2 to SARS-CoV-2 variants of concern indicate that mutations enabling immune escape could expand host range

Challenges of COVID-19 Case Forecasting in the US, 2020-2021

Anti-sars-cov-2 antibodies and use thereof in the treatment of sars-cov-2 infection

Cryo-EM structures and binding of mouse and human ACE2 to SARS-CoV-2 variants of concern indicate that mutations enabling immune escape could expand host range